knowledge -WSS

knowledge

author：explore 2025-09-30 21:22:28 - browse：3166

Portrait of Robert Langer. -- biotech coverage from STAT. — Serial biotech entrepreneur Bob Langer will serve as an adviser to T.rx Capital. Pat Greenhouse/Globe Staff

Executives from the shuttered digital health company Pear Therapeutics are launching a new VC firm, offering early access to new startups formed by serial biotech entrepreneur Bob Langer.

Former Pear CEO Corey McCann and former licensing head Michael Langer formed the new firm, T.rx Capital, earlier this year, according to three people with knowledge of the firm and documents reviewed by STAT. Michael Langer, the son of Bob Langer, confirmed the news and that they had set a $175 million cap for its first fund.

The firm will invest in therapeutics and digital health products by both forming new companies and taking pitches from early-stage startups. T.rx has brought in Everly Health executive Liz Kwo and Caris Life Sciences vice president Debbie Lin as venture partners, while current Eli Lilly business development team member Kwesi Frimpong-Boateng will be joining T.rx’s founding team. Bob Langer is a scientific adviser.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Cancer researcher Catriona Jamieson is sending tumors into space

WSS

Cue Health's Covid

Congressmen charge Covid hearing ‘could have been an email’

Apple Vision Pro: A first look at health apps on the new VR headset

Cue Health's Covid

Vertigo drug brings hope for rare neuron disorder, Niemann

Cognito secures funding to test medical device for Alzheimer's

leisure time

knowledge

hotspot

Psychedelics group wrestles with new pharma identity

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Moonlake's readout produced a cash windfall. Risks remain

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Novo Nordisk to expand supply of Wegovy for U.S. patients

After affirmative action ruling, medical educators look to 'holistic review'

Melinda French Gates resigns from Gates Foundation

Wildfire smoke exposes gaps in outdoor worker protections

More tobacco lobbyists active in statehouses

knowledge

Q&A: Jennifer Adair on making gene therapy available globally

Orangutan used medicinal plant to treat wound, first time ever seen

Commercial surrogacy can be ethical, despite pope’s claims

MassMutual is introducing free genetic testing for members

Do digital therapeutics have a future in medicine?

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

knowledge

focus

focus

entertainment